| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.057 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.029 | 0.9 |